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Sixteen lactating Nili-Ravi buffaloes were used to observe the effect of recombinant 
bovine somatotropin (rbST) on haematological profile. These buffaloes were 
divided into two groups, with eight buffaloes in each group. Buffaloes of group I 
were injected with sterilized normal saline to serve as control. Animals in group II 
were administered 500 mg of rbST subcutaneously, twice at an interval of 16 days. 
Blood with anticoagulant was collected to determine DLC, ESR and PCV. Overall 
mean ESR decreased significantly (5.74%) in rbST injected buffaloes as compared 
to control at the end of experimental period. Neutrophils percent decreased and 
lymphocytes percent increased significantly in rbST treated buffaloes compared to 
control. Packed cell volume, basophils, monocytes and eosinophils did not differ 
significantly between the two groups. In conclusion, high dose of rbST did not 
result in alteration of certain haematological parameters in buffaloes. 
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INTRODUCTION 
 
Nili-Ravi is the most popular breed of buffaloes 
which constitutes about 76.7% of the total buffalo 
population in Pakistan (Otto et al., 2003). Nili-Ravi 
animals are highly important asset for the country, having 
a great potential for milk produced. Buffaloes contribute 
approximately 67% of total milk production in the country 
(Bhatti et al., 2009). However, much more needs to be 
done to exploit their potential for enhanced milk yield, 
using present day industry practices. Over the years, an 
overall increase in milk production in the country has 
taken place, but this increase is not a reflection of increase 
in per animal milk yield, rather it is merely due to increase 
in the number of animals (Anonymous, 2007). Some 
increase in total annual milk production in the country is 
because of crossbreds and a bit of it can be attributed to 
the use of artificial insemination services in buffaloes and 
cows but this is due to limited impact of breeding schemes 
through selection and artificial insemination etc. (Otto et 
al., 2003).  
The first major agriculture related product of 
biotechnology research was bovine somatotropin (bST). 
Naturally produced by a cow’s pituitary gland, bST is one 
of the hormones involved in normal body growth, 
development of mammary glands and normal milk 
production (Murphy, 1998; Bhatti et al., 2007). Injections 
of crude pituitary extracts increased milk production in 
dairy cows (Lee and Schaffer, 1934), but its limited 
supply made field application impractical. Later in 1982, 
synthetic bST was produced by DNA biotechnology by 
Monsanto (US based corporation) that allowed scientists 
around the world to examine various aspects of its 
biology. 
Use of recombinant bovine somatotropin (rbST) as a 
powerful tool to enhance cattle performance in terms of 
milk production has been reviewed by Peel and Bauman, 
(1987). While most studies either pertain to cattle, 
crossbred animals and to some extent with sheep 
(Fernandez et al. 1995) and goats (Disenhaus et al. 1995), 
only single study on buffaloes was reported by Ludri et al. 
(1989). These studies are either short term (14 days) or 
long term, mostly using the recommended dose (250 
mg/14 days) of rbST. A dose dependence was also 
conceived by Chilliard (1988b), who reported 2.8 Kg/day 
increase in milk with 31-50 mg/day of rbST. He further 
emphasized that response to rbST was very rapid and was 
maximum after one week or less. McGuffey et al. (1987) 
and Verite et al. (1988) reported that increasing the 
injection frequency with the same total amount of bST did 
not change the milk response. However, feeding and 
management factors could contribute and bring some 
alteration in the composition of milk. As bST injection is 
time dependent (Chilliard, 1988a), maximal milk yield 
was obtained when animals had already passed one month 
of lactation period. However, milk response to bST was 
found to be of the same magnitude as compared to first 
lactation of these animals. The purpose of the present Pakistan Vet. J., 2010, 30(1): 53-57. 
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study was to evaluate the effect of high dose (500 mg) of 
rbST on certain haematological parameters of Nili-Ravi 
buffaloes.    
 
MATERIALS AND METHODS 
 
The present study was carried out at the Livestock 
Experiment Station, University of Agriculture Faisalabad, 
Pakistan and included 16 clinically healthy Nili-Ravi 
buffaloes aged 7-10 years at 3-4 months post calving and 
in their second to fourth lactation season. During the 
experimental period, the minimum and maximum 
environmental temperatures were 12 and 33
0C and 
average relative humidity was recorded to be 71 percent. 
Temperature humidity index was calculated to be 67.31. 
All buffaloes were housed under the same experimental 
conditions and were on free stalls, fed mixed ration 
(sugarcane and Barseem fodder and maize oil cake; 
Rafhan Products Co. Limited, Faisalabad; Table 1) 
according to their milk yield. Experimental buffaloes were 
divided into group I (n=8) to serve as control, while 
buffaloes in group II (n=8) were injected with 500 mg 
rbST subcutaneously twice during the experimental period 
at an interval of 16 days. 
 
Table 1: Chemical composition of sugarcane and 
Berseem offered to each buffalo during 
experimental period 
 Sugarcane 
(%) 
Berseem 
(%) 
Dry matter   31.8  13.9 
Organic matter   94.9  88 
Crude protein  6.2  20.4 
No-digestible fiber   50.5  54.0 
Acid detergent fiber (ADF)  28  27 
Soluble carbonate   46.7  18.4 
Hemicellulose   22.5  27.4 
Ash   5.1  12.0 
 
Buffaloes were properly restrained for collection of 
blood samples on day 0, 1, 4, 8, 12, 16, 17, 20, 24, 28 and 
32 with a sterile hypodermic needle (18 gauge, 5 cm 
long). Blood was collected in test tubes containing 
anticoagulant (heparin; as 1% for 10 ml blood) for 
haematological studies. All tests were performed in 
duplicate. Thin blood films were made immediately after 
the blood collection, fixed with methanol and stained with 
Modified Giemsa’s stain solution (Benjamin, 1985). The 
stained blood films were examined under the oil 
immersion lens by using the battlement technique of 
counting. The leukocytes were classified as lymphocytes, 
monocytes, neutrophils, eosinophils and basophils. Three 
persons were allotted these slides without identification of 
groups and animals for counting. Erythrocyte 
sedimentation rate (ESR) was recorded by using 
Westergeren tube (Benjamin, 1985). The packed cell 
volume (PCV) was noted as percentage with the help of 
haematocrit scale as described by Bush (1991).  
Means and standard error of means were calculated. 
Two way analysis of variance was performed to determine 
the difference between days of experiment, between 
groups as well as days x groups interaction (Steel et al., 
1997). Duncan’s Multiple Range (DMR) test was applied 
to see the differences between means (Duncan, 1955). 
Linear correlation coefficients were calculated between 
haematological profiles of normal and rbST treated 
buffaloes with that of milk and serum biochemical 
parameters recorded during the experiment.  
 
RESULTS 
 
Overall mean erythrocyte sedimentation rate (ESR) 
decreased significantly (P<0.01) in rbST treated buffaloes 
as compared to control buffaloes (Table 2). A decrease of 
5.74 and 2.86% in ESR was observed in control and rbST 
treated group, respectively after 1
st injection. Also, a 
significant decrease of ESR (6.85%) in control and an 
increase of 0.45% in rbST injected buffaloes was 
observed after 2
nd injection. However, between days of 
injection, ESR did not differ significantly (Table 2). 
Overall mean PCV in control and treated buffaloes 
was 33.36 ± 0.41 and 32.76 ± 0.32 percent respectively 
(Table 2). The PCV did not differ between days of 
treatment, or between the two groups at any stage of 
treatment. 
 
Table 2: Mean erythrocyte sedimentation rate and pack cell volume of control and bovine somatotropin injected 
buffaloes at various days 
Erythrocyte sedimentation rate (ESR; mm/hr)    Pack cell volume (PCV; %)   
Days  Control  bST  Overall mean  Control  bST  Overall mean 
0  92.63 ± 4.07  82.13 ± 3.19  87.38 ± 2.84  34.19 ± 0.95  33.38 ± 0.92  33.78 ± 0.65 
1
st Injection 
1  85.63 ± 4.38  79.50 ± 2.05  82.56 ± 2.47  34.06 ± 1.10  33.31 ± 0.95  33.69 ± 0.71 
4  90.38 ± 4.23  77.50 ± 2.02  83.94 ± 2.81  34.19 ± 1.18  33.25 ± 0.94  33.72 ± 0.74 
8  86.63 ± 4.23  79.88 ± 2.45  83.25 ± 2.52  35.19 ± 1.19  32.75 ± 0.97  33.97 ± 0.81 
12  85.25 ± 4.31  82.13 ± 3.62  83.69 ± 2.75  33.88 ± 1.39  33.50 ± 0.81  33.69 ± 0.78 
16  88.63 ± 5.13  79.88 ± 2.34  84.25 ± 2.95  31.06 ± 2.62  32.75 ± 0.93  31.91 ± 1.36 
2
nd Injection 
17  87.50 ± 3.65  80.13 ± 2.89  83.81 ± 2.44  32.31 ± 1.25  31.81 ± 1.16  32.06 ± 0.83 
20  89.38 ± 3.44  82.00 ± 3.49  85.69 ± 2.55  32.88 ± 1.11  32.69 ± 1.22  32.78 ± 0.79 
24  85.25 ± 4.63  85.13 ± 3.87  85.19 ± 2.92  34.06 ± 1.18  33.45 ± 1.13  33.76 ± 0.79 
28  86.88 ± 6.48  84.63 ± 4.42  85.75 ± 3.80  33.19 ± 0.98  32.01 ± 1.26  32.60 ± 0.79 
32  82.38 ± 4.31  80.63 ± 4.21  81.60 ± 2.92  31.94 ± 1.20  31.45 ± 1.49  31.69 ± 0.93 
Overall means  87.32 ± 1.31
A 81.23  ±  0.95
B  84.27 ± 0.84  33.36 ± 0.41  32.76 ± 0.32  33.06 ± 0.26 
Values with similar alphabets in a row do not differ significantly (P≥0.01). Pakistan Vet. J., 2010, 30(1): 53-57. 
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Overall highest lymphocytes (%) was observed on day 24 
after 2
nd injection, while lowest was on days 1 and 16 of 
first injection of rbST. Overall mean lymphocytes were 
significantly higher in rbST treated as compared to control 
buffaloes (Table 3). Overall neutrophils percentage 
decreased significantly on day 24 (Table 3) of 2
nd 
injection compared to pretreatment values. Throughout 
the experimental period, buffaloes injected with rbST 
showed significantly lower percentage of neutrophils as 
compared to control animals and on overall basis, treated 
buffaloes had lower neutrophils compared to control 
(P<0.01). Mean eosinophils count of control and rbST 
injected buffaloes did not differ at any stage of the 
experimental period. Overall highest counts of monocytes 
were observed on day 1 and 12 after 1
st injection and on 
28 and 32 after 2
nd injection (Table 3). Overall mean 
basophils count of control and rbST injected buffaloes 
were within normal ranges throughout the experimental 
period and did not differ among days of treatment or 
between treated and control groups. 
 
DISCUSSION 
 
A significant decrease in erythrocyte sedimentation 
rate was observed in rbST treated buffaloes compared to 
control. Haemoglobin and hematocrit have been reported 
to decline slightly with increasing dose of bST as well as 
milk yield (Staple et al., 1988). Likewise, a significant 
reduction in packed cell volume has been reported by Bolt 
(1980) and Bines and Hart (1982). This decrease was 
attributed to the dilution effect of the blood as bST 
treatment caused increase in the moisture contents in the 
carcass as well as in some organs. Hematocrit was 
significantly lower in cows given 41.2 mg rbST/day as 
compared to cows receiving 0, 10.3 and 26.6 mg rbST/day 
(Soderholm  et al., 1988). Therefore, it seems that 
significant decrease in ESR and a decreasing pattern of 
packed cell volume were related to bST treatment rather 
than milk yield or may be in addition to milk yield. Zvorc 
et al. (2006) observed a decrease in haemoglobin and 
MCH during normal lactation in animals.  
Various haematochemical parameters show changes 
during growth, pregnancy and lactation (Eppard et al., 
1997). Hematocrit and haemoglobin concentration are 
high in non-lactating cows which then decrease post-
partum until 3
rd or 4
th month of lactation and increase 
afterward (Rowlands, 1980; Stevens et al., 1980). It has 
been reported that cows with higher milk production have 
lower hematocrit as compared to low yielding cows 
(Whitlock et al., 1974; Stevens et al., 1980). 
Eppard  et al. (1997) reported that during bST 
treatment a decrease in RBC count and hematocrit was 
observed, in addition to concomitant decrease in 
haemoglobin and RBC distribution. These changes were 
attributed to normal adjustment to change in the 
physiological state. As speculated by Eppard et al. (1997), 
clinically depressed hematocrit is associated with one of 
three general disorders; 1) increased hemalysis or 
shortened RBC survival, 2) alteration of the fluid phase of 
circulating volume and 3) decreased erythropoisis. 
Additionally, bST did not affect the appearance of 
immature red blood cells which tended to decrease rather 
than to increase mean cell volume and marginally affected 
serum bilirubin concentration. 
In the present study, lympocytes increased, while 
neutrophils decreased significantly in rbST injected 
buffaloes as compared to controls. Eosinophils, 
monocytes and basophils did not show any change due to 
rbST treatment. Oldenbroek and Gassen (1993) observed 
a slight increase in lymphocytes following rbST treatment 
in dairy cows that was within physiological limits. Burton 
et al. (1992) reported that lympocytes fraction decreased 
at week 26 and 35 of bST treatment and these values 
increased to control value as the treatment was terminated. 
On the other hand, Annexstad et al. (1990) observed no 
effect of rbST treatment on lymphocyte percent after bST 
treatment. The present study in buffaloes indicated that 
lymphocytes increased significantly on day 20
th and were 
highest on day 24
th and 28
th after 2
nd injection of bST. In 
vitro studies conducted by Burton et al. (1992) speculated 
that peripheral blood lymphocytes from treated cows 
displayed an elevated proliferated responsiveness to 
mitogens and a significant decrease in neutrophils percent 
in culture. Lymphocytes in the present study were 
significantly correlated (r = 0.740) with milk production, 
milk fat and milk lactose concentrations, while a negative 
correlation was observed with milk protein in rbST 
injected buffaloes. 
A significant decrease in neutrophils in bST treated 
buffaloes compared to controls in the present study is 
supported by Burton et al. (1992), who indicated that 
neutrophils fraction for 20.6 mg/d of rbST injected cows 
dropped dramatically and then reached control values by 
last week of treatment i.e. 46 weeks. Neutrophils were 
negatively correlated with milk production, milk fat and 
lactose, and positively correlated with milk protein in bST 
treated buffaloes. These results are also consistent with 
the notion that bST is granulopoietic (Kelley, 1989).  
In the present study, the values of lymphocytes and 
neutrophils remained within physiological limits which 
suggest that rbST treatment with 500 mg/15 day had no 
adverse effects on animal health. No significant 
differences were observed in eosinophils, monocytes and 
basophils after rbST treatment in buffaloes, which is 
according to the observations recorded by Annexstad et 
al. (1990), McGuffey et al. (1991) and Oldenbroek and 
Gassen (1993). Overall mean monocytes increased 
significantly on day 1 and 12 of first rbST injection and 
on day 28 and 32 of 2
nd injection. Variation in monocytes 
percentage was also observed by Burton et al. (1992) in 
rbST injected cows and was suggestive of the presence of 
IGF-1 concentration in the blood plasma. Burton et al. 
(1992) further observed that neutrophils and lymphocytes 
possess cellular receptors for IGF-I and that IGF-I can be 
produced by the leukocytes. 
In conclusion, our study is suggestive of a significant 
increase in lymphocytes, while neutrophils and ESR 
decreased but were within physiological limits after two 
connective injections of 500 mg of rbST at an interval of 
15 days in buffaloes. 
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